GlaxoSmithKline Pharmaceuticals Limited (GLAXO) — Long-term Investment Intensity
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Long-term Investment Intensity of 0.0% as of September 2019. Long-term investments of Rs600.00K represent 0.0% of total assets of Rs35.20 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See GlaxoSmithKline Pharmaceuticals Limited (GLAXO) net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
GlaxoSmithKline Pharmaceuticals Limited Long-term Investment Intensity (2014–2019)
This chart shows how GlaxoSmithKline Pharmaceuticals Limited's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of September 2019, the intensity stands at 0.0%, reflecting long-term investments of Rs600.00K against total assets of Rs35.20 Billion INR. Also explore GLAXO current and non-current assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for GlaxoSmithKline Pharmaceuticals Limited (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for GlaxoSmithKline Pharmaceuticals Limited from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see GLAXO market cap.
| Year | LT Investment Intensity | LT Investments (INR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.0% | Rs550.00K | Rs39.11 Billion | ▲ +0.0 pp |
| 2018 | 0.0% | Rs550.00K | Rs39.47 Billion | ▼ 0.0 pp |
| 2017 | 0.0% | Rs550.00K | Rs30.04 Billion | ▲ +0.0 pp |
| 2016 | 0.0% | Rs550.00K | Rs30.46 Billion | ▼ 0.0 pp |
| 2015 | 0.0% | Rs695.00K | Rs32.24 Billion | ▲ +0.0 pp |
| 2014 | 0.0% | Rs550.00K | Rs31.30 Billion | — |